Elizabeth Birch

Elizabeth Birch currently serves as the Head of Business Development at Muna Therapeutics since July 2023. Prior to this role, Elizabeth held the position of VP of Business Development at Neumora from June 2020 to June 2023 and acted as Interim Chief Operating Officer at Guide Therapeutics from June 2019 to May 2020. Elizabeth also worked as an Investor at Biomatics Capital between October 2017 and May 2020 and was a Consultant at L.E.K. Consulting from September 2013 to October 2017, specializing in the life sciences practice. Elizabeth Birch earned a Bachelor's degree in Biology and a DPhil in Fungal Pathology from the University of Oxford.